Dyslipidemia

Ragavendra R. Baliga, Christopher P. Cannon (Herausgeber)

Buch | Softcover

152 Seiten

2011
Oxford University Press Inc (Verlag)
978-0-19-974286-8 (ISBN)

Artikel merken

Dyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardial infarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control.

As part of the Oxford American Cardiology Library, this practical handbook is designed to serve as a concise yet authoritative resource on diagnosing and treating dyslipidemia. The book is tailored to the needs of busy health care professionals treating patients in various clinical settings, and focuses on presenting essential information to clinicians who are at the forefront of the diagnosis and management of dyslipidemia. Featuring evidence-based, concise yet comprehensive discussion of key clinical concepts in addition to numerous figures, tables and illustrations, this pocket-sized handbook will serve as an invaluable guide to healthcare professionals.

Ragavendra R. Baliga, MD, MBA, FACC, FRCP, is Vice Chief & Assistant Division Director, and Professor of Internal r s1cine at The Ohio State University Medical Center in Columbus, Ohio. Christopher P. Cannon, MD, is Associate Professor of Medicine at Harvard Medical School and Associate Physician, Cardiovascular Division, at Brigham and Women's Hospital in Boston, Massachusetts.

Contributors ; 1. LDL Cholesterol ; 2. HDL Cholesterol ; 3. Non-HDL Cholesterol ; 4. Use of High Sensitivity C-reactive Protein for Risk Assessment ; 5. Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements ; 6. Stratification of Dyslipidemic Risk ; 7. Drugs for Treatment of Blood Lipoprotein Abnormalities ; Index

Erscheint lt. Verlag	15.12.2011
Reihe/Serie	Oxford American Cardiology Library
Verlagsort	New York
Sprache	englisch
Maße	198 x 127 mm
Gewicht	187 g
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie
Themenwelt	Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie
ISBN-10	0-19-974286-3 / 0199742863
ISBN-13	978-0-19-974286-8 / 9780199742868
Zustand	Neuware